I’m a DPhIl student, and I’m interested in T-box transcription factors and their roles in cancer progression, with a special focus on understanding how they help pre-malignant lesions bypass oncogene-induced senescence. I’m working on identifying new targets of TBX2 and TBX3, by combining RNA-seq and ChIP-seq.
Before coming to LICR Oxford, I did my Master’s at the UCL School of Pharmacy. My research project was to design small peptide inhibitors to prevent degradation of the tumour suppressor Nrf2 for cancer prevention. Prior to that, I did my undergraduate degree in Shenyang Pharmaceutical University in China, majoring in Traditional Chinese Medicine.